Sign up to save your podcasts
Or
Share New Insights into Lysosomal Storage Diseases’ Pathophysiology is Changing Treatment
Share to email
Share to Facebook
Share to X
Share to email
Share to Facebook
Share to X
Or
New Insights into Lysosomal Storage Diseases’ Pathophysiology is Changing Treatment
Drs Ozlem Goker-Alpan and Gregory Grabowski discuss how new research into the pathophysiology of lysosomal storage diseases is changing how we manage these rare diseases. .
This CME/CE activity is possible through an educational grant from Takeda, Cheisi, Ultragenyx Pharmaceuticals, and Spark Therapeutics.
To obtain credit for this activity, please visit https://checkrare.com/learning-center/courses/
This CME/CE activity is possible through an educational grant from Takeda, Cheisi, Ultragenyx Pharmaceuticals, and Spark Therapeutics.
To obtain credit for this activity, please visit https://checkrare.com/learning-center/courses/
View all episodes
By Peter Ciszewski, CheckRare
5
33 ratings
Drs Ozlem Goker-Alpan and Gregory Grabowski discuss how new research into the pathophysiology of lysosomal storage diseases is changing how we manage these rare diseases. .
This CME/CE activity is possible through an educational grant from Takeda, Cheisi, Ultragenyx Pharmaceuticals, and Spark Therapeutics.
To obtain credit for this activity, please visit https://checkrare.com/learning-center/courses/
This CME/CE activity is possible through an educational grant from Takeda, Cheisi, Ultragenyx Pharmaceuticals, and Spark Therapeutics.
To obtain credit for this activity, please visit https://checkrare.com/learning-center/courses/